| 摘要: |
| 目的 运用网状Meta分析系统对国产和进口多奈哌齐治疗痴呆的有效性和安全性进行评估,以期为临床治疗痴呆的药物选择提供可借鉴的可靠依据。方法 通过计算机应用不同的检索策略,使用不同的检索方法,检索PubMed、Embase、Cochrane Library、CNKI、万方数据和中国生物医学文献数据库,收集包含有关国产和进口多奈哌齐治疗痴呆的随机对照试验(RCT),检索时间范围为1996年1月—2024年1月,研究人员独立地筛选文献、提取数据和评介研究的偏倚风险,并使用Stata 17.0软件进行网状Meta分析。结果 共纳入研究34项,涉及3 432例患者。网状 Meta 分析结果显示,国产多奈哌齐(累积排序曲线下面积SUCRA为0.983)治疗痴呆的疗效优于进口多奈哌齐SUCRA为0.748),进口多奈哌齐(SUCRA为0.855)的MMSE评分优于国产多奈哌齐(SUCRA为0.640),进口多奈哌齐(SUCRA为0.537)不良反应发生率相比国产多奈哌齐(SUCRA为0.499)略低。结论 现有证据表明,进口多奈哌齐较国产多奈哌齐在疗效和安全性方面总体相似,但因受当前研究数量和质量的限制,还需要更多高质量、大样本研究来验证这一结论。 |
| 关键词: 痴呆 多奈哌齐 网状Meta分析 随机对照试验 |
| DOI:10.13506/j.cnki.jpr.2025.06.017 |
| 基金项目:山东省自然科学基金资助项目(No.ZR2022MH250);山东省药品临床综合评价项目(No.2022YZ027);山东省医学会临床科研资金齐鲁专项(No.YXH2022ZX02050);山东省医药卫生科技项目(No.202313010259、202413050441) |
|
出版日期:2025-06-25
|
|
| Efficacy and safety of Donepezil Hydrochloride Tablets in the treatment of dementia: a network Meta-analysis |
| GUAN Yuyao,WU Yubao,JI Jingchao,HAN Tongzhou,ZHENG Lei |
| (Department of Pharmacy, Shandong Provincial Third Hospital, Jinan 250031, China) |
| Abstract: |
| Objective To assess the effectiveness and safety of both domestic and international donepezil in treating dementia via a network meta-analysis, offering a more dependable guide for clinical medication choices in managing dementia.Methods An extensive search was performed across PubMed, Embase, Cochrane Library, CNKI, WanFang Data, and CBM databases to gather randomized controlled trials (RCTs) that evaluated domestic versus imported donepezil for dementia treatment, covering the period from January 1996 to January 2024.Two investigators separately reviewed the literature, collected data, and evaluated the potential for bias in the studies considered. A network meta-analysis was conducted utilizing Stata 17.0 software.Results 34 studies with a combined total of 3,43 participants were included. The outcomes of the network meta-analysis indicated that domestic donepezil (Surface Under the Cumulative Ranking curve, SUCRA =0.983) was more effective in treating dementia than imported donepezil (SUCRA =0.748). However, imported donepezil (SUCRA =0.855) showed better MMSE scores than domestic donepezil (SUCRA =0.640). The incidence of adverse reactions was slightly lower with imported donepezil (SUCRA =0.537) compared to domestic donepezil (SUCRA =0.499).Conclusion Current evidence suggests that the overall efficacy and safety of imported and domestic donepezil are similar.Nonetheless, because the quantity and caliber of the studies included are restricted, additional large-scale, high-quality research is necessary to confirm these results. |
| Key words: Dementia Donepezil Network meta-analysis Randomized controlled trial |